These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36002937)

  • 41. In Vitro-In Vivo Correlation of Blood-Brain Barrier Permeability of Drugs: A Feasibility Study Towards Development of Prediction Methods for Brain Drug Concentration in Humans.
    Ito R; Morio H; Baba T; Sakaguchi Y; Wakayama N; Isogai R; Yamaura Y; Komori T; Furihata T
    Pharm Res; 2022 Jul; 39(7):1575-1586. PubMed ID: 35288803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TrimNet: learning molecular representation from triplet messages for biomedicine.
    Li P; Li Y; Hsieh CY; Zhang S; Liu X; Liu H; Song S; Yao X
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
    Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
    Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.
    Patabendige A
    Methods Mol Biol; 2022; 2492():131-142. PubMed ID: 35733042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can we predict blood brain barrier permeability of ligands using computational approaches?
    Kumar R; Sharma A; Tiwari RK
    Interdiscip Sci; 2013 Jun; 5(2):95-101. PubMed ID: 23740390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations.
    Carpenter TS; Kirshner DA; Lau EY; Wong SE; Nilmeier JP; Lightstone FC
    Biophys J; 2014 Aug; 107(3):630-641. PubMed ID: 25099802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methods to assess drug permeability across the blood-brain barrier.
    Nicolazzo JA; Charman SA; Charman WN
    J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A merged molecular representation learning for molecular properties prediction with a web-based service.
    Kim H; Lee J; Ahn S; Lee JR
    Sci Rep; 2021 May; 11(1):11028. PubMed ID: 34040026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alvascience: A New Software Suite for the QSAR Workflow Applied to the Blood-Brain Barrier Permeability.
    Mauri A; Bertola M
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
    Wang YI; Abaci HE; Shuler ML
    Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Traditional Machine and Deep Learning for Predicting Toxicity Endpoints.
    Norinder U
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Blood-Brain Barrier (BBB) Score.
    Gupta M; Lee HJ; Barden CJ; Weaver DF
    J Med Chem; 2019 Nov; 62(21):9824-9836. PubMed ID: 31603678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Finding Needles in a Haystack: Determining Key Molecular Descriptors Associated with the Blood-brain Barrier Entry of Chemical Compounds Using Machine Learning.
    Majumdar S; Basak SC; Lungu CN; Diudea MV; Grunwald GD
    Mol Inform; 2019 Aug; 38(8-9):e1800164. PubMed ID: 31322827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. circRNA-binding protein site prediction based on multi-view deep learning, subspace learning and multi-view classifier.
    Li H; Deng Z; Yang H; Pan X; Wei Z; Shen HB; Choi KS; Wang L; Wang S; Wu J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34571539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of separation methods for in vitro prediction of blood-brain barrier permeability-The state of the art.
    Ciura K; Dziomba S
    J Pharm Biomed Anal; 2020 Jan; 177():112891. PubMed ID: 31568968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
    Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
    Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood-brain barrier penetration prediction enhanced by uncertainty estimation.
    Tong X; Wang D; Ding X; Tan X; Ren Q; Chen G; Rong Y; Xu T; Huang J; Jiang H; Zheng M; Li X
    J Cheminform; 2022 Jul; 14(1):44. PubMed ID: 35799215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of experimental models of the blood-brain barrier in CNS drug discovery.
    Palmer AM; Alavijeh MS
    Curr Protoc Pharmacol; 2013 Oct; 62():7.15.1-7.15.30. PubMed ID: 24510719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.